US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

242.35

-1.3764-0.56%

Volume:2K

Turnover:549.22K

Market Cap:479.01M

PE:- -

High:242.41

Open:242.41

Low:242.26

Close:243.73

52wk High:244.35

52wk Low:160.91

Shares:1.98M

Float Shares:1.98M

Volume Ratio:0.29

T/O Rate:0.11%

Dividend:0.95

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know

Global Drugmakers Invest Billions to Boost US Presence

Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback

THOMSON REUTERS

Erasca Appoints Charles Fuchs as President of R&D

Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank

Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)

BeOne Medicines partners with Revolution Medicines for clinical development

BeOne Medicines Teams with Revolution Medicines on RAS Cancer Drug Development, Asia Rights Deal

Beone Medicines - Receives Exclusive Rights to Four Revolution Medicines Assets in Select Asian Markets

THOMSON REUTERS

Beone Medicines - to Fund and Conduct Global Phase 3 Study for Ras(on) Inhibitor

THOMSON REUTERS

Beone Medicines - Revolution Medicines Eligible for Milestone Payments and Tiered Royalties in Partnered Region

THOMSON REUTERS

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Amgen Inc : HSBC Raises Target Price to $445 from $425

THOMSON REUTERS

Revolution Medicines, Inc. : JP Morgan Raises Target Price to $227 from $205

THOMSON REUTERS

Analysts Are Bullish on These Healthcare Stocks: Spyre Therapeutics (SYRE), Revolution Medicines (RVMD)

Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million

Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Climbs 9.9%, Outperforms Peers

Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BBH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":242.35,"timestamp":1787763355916,"preClose":243.7264,"halted":0,"volume":2266,"delay":0,"changeRate":-0.005647316006801142,"floatShares":1976503,"shares":1976503,"eps":0,"marketStatus":"Trading","change":-1.3764,"latestTime":"08-26 12:57:16 EDT","open":242.41,"high":242.41,"low":242.2645,"amount":549217.12736,"amplitude":0.000597,"askPrice":242.66,"askSize":200,"bidPrice":242.44,"bidSize":244,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787774400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":243.7264,"sharesOutstanding":1976503,"nav":240.10472,"aum":474567706.07,"dividendRate":0.003922,"bidAskSpread":0.00128,"preHourTrading":{"tag":"盘前","latestPrice":242.87,"preClose":243.7264,"latestTime":"09:29 EDT","volume":223,"amount":54165.1613,"timestamp":1787750999999,"change":-0.8564,"changeRate":-0.003514,"amplitude":0.003488},"postHourTrading":{"tag":"盘后","latestPrice":243.48,"preClose":243.7264,"latestTime":"19:30 EDT","volume":15,"amount":3655.9176,"timestamp":1787700602077,"change":-0.2464,"changeRate":-0.001011,"amplitude":0},"volumeRatio":0.292372,"impliedVol":0.2219,"impliedVolPercentile":0.8247},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":1976503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.292372,"shares":1976503,"dividePrice":0.9505,"high":242.41,"amplitude":0.000597,"preClose":243.7264,"low":242.2645,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":242.35,"committee":0.099099,"eps":0,"divideRate":0.003922,"volume":2266,"delay":0,"ttmEps":0,"open":242.41,"prevYearClose":189.2649,"prevWeekClose":241.2282,"prevMonthClose":205.5494,"prevQuarterClose":203.2373,"fiveDayClose":244.0166,"twentyDayClose":208.643,"sixtyDayClose":185.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658713934","title":"Vertex Pharmaceuticals Inc Stock (VRTX) Opened Up by 9.76% on Aug 10: What Investors Need To Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2658713934","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658713934?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:47","pubTimestamp":1786369636,"startTime":"0","endTime":"0","summary":"• Vertex reported positive Phase 3 data for its non-opioid pain treatment candidate.\n• The company raised its full-year revenue guidance following successful international product launches.\n• Analysts maintain a Buy rating with an average price target of $557.64.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262092805-market-movers-vrtx-20260810","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","BBH","IBBQ","IDNA","LU0057025933.USD","IE000F7OJYX1.SGD","IE0004445239.USD","LU1023059063.AUD","IE00BBT3K403.USD","GLAM","IXJ","LU1559883803.SGD","VEGI","TBXU","FTXH","VHT","RXL","LU0511384066.AUD","VRTX","LU2433249047.HKD","BIB","LU0868494708.USD","PBE","AZN","LU1585245621.USD","IE000WAW04H5.SGD","PPH","TRUH","LU0098860793.USD","VERX","LU0289739343.SGD","LU1839511570.USD","AZNH","AGNG","LU0170899867.USD","XLV","CF","GNMX","JDOC","MEDX","ABBV","FHLC","IYH","LU0795875169.SGD","LU0114720955.EUR","IBB","LU1934455277.USD","BK4139","PJP","ISBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931607","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931607?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:16","pubTimestamp":1786367800,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 10 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1228905037.USD","LU2125154778.USD","LU2462157665.USD","LU0353189680.USD","IE0009355771.USD","LU2468319806.SGD","LU0889566641.SGD","LU1037948897.HKD","LU2242646821.SGD","GSK.UK","LU0170899867.USD","LU1732799900.SGD","LU1162221912.USD","LU2168563687.JPY","LU0823416689.USD","SGXZ99366536.SGD","BK4504","IE00B775H168.HKD","LU2028103732.USD","IE000SO60NU8.SGD","LU0683600562.USD","JNJ","LLYX","LU0267386448.USD","IE00BVYPNV92.GBP","IE00BK4W5L77.USD","LU2023250504.SGD","LU2213496289.HKD","IE00B1XK9C88.USD","LU1868836757.USD","LU2023250843.SGD","LU0306806265.USD","LU2063271972.USD","LU2746668461.USD","HRTS","LU2491050071.SGD","IE00BWXC8680.SGD","LU0158827948.USD","LLII","LU1066053197.SGD","SG9999014542.SGD","LU2602419157.SGD","TMED","LU1548497426.USD","LU2505996681.GBP","LU0289739699.SGD","LU1670710661.SGD","SG9999011175.SGD","LU0426412945.USD","LU2237443549.SGD","SG9999014914.USD","LU0882574139.USD","LU1061106388.HKD","LU1929549753.HKD","SG9999015952.SGD","LU0203202063.USD","IE0002141913.USD","BK4550","BK4533","LU2237443622.USD","IE00BKPKM429.USD","LU0069063385.USD","LU2106854487.HKD","LU0128525929.USD","SG9999001176.USD","TRUH","LU0820562030.AUD","BIB","WDNA","LU0133085943.USD","LU2237438978.USD","LU0198837287.USD","LU1043141396.HKD","LU1127390331.HKD","LU2750360997.AUD","LU0792757196.USD","LU1093756325.SGD","LU1670711123.USD","LU1506573853.SGD","LU1934455277.USD","PAWZ","IE000F7OJYX1.SGD","LU0471298694.HKD","LU1291159041.SGD","LU2487616109.SGD","LU2361044949.HKD","LU1074936037.SGD","LU0354030511.USD","IE00B19Z9Z06.USD","LU1228905540.USD","SG9999014567.USD","LU0820561818.USD","LU0964807845.USD","LU0097036916.USD","BBH","LU2237443465.HKD","LU0130102774.USD","LU2129689514.USD","LU0109391861.USD","LU0787776722.HKD","BK4583","BK4559","LU1032955483.USD","LU1670628061.USD","LU1989772923.USD","BMED","LU2361045086.USD","IE00BJT1NW94.SGD","LU1551013425.SGD","LU0029864427.USD","BK4578","IE00BJJMRY28.SGD","LU1043141123.HKD","LU1232071149.USD","BK4581","IE0004445239.USD","LU0234570918.USD","BK4592","LU1883839398.USD","IE00BJJMRZ35.SGD","LU0949170772.SGD","IE00BLSP4239.USD","LU2089283258.USD","LU0098860793.USD","SG9999001176.SGD","CURE","LU0237698245.USD","LU1035775433.USD","IE000WAW04H5.SGD","LU0158827781.USD","LU1267930813.SGD","XLV","IHE","LU0094547139.USD","LU1989772840.SGD","LU2347655073.USD","LU0057025933.USD","GB00BDT5M118.USD","IBB","IE00BGHQF631.EUR","LU1037948541.HKD","IE00B3PB1722.GBP","LU1035773651.USD","LU2324357040.USD","LU0994945656.USD","LU2023251221.USD","PBE","LU1935042991.SGD","IE00B3T34201.USD","LU1267930730.SGD","LU1623119135.USD","IE00BBT3K403.USD","LU0310800379.SGD","LU2756315318.SGD","LU0726765562.USD","LU1778281490.HKD","LU1718418525.SGD","LU0985481810.HKD","LU1280957306.USD","LU0208291251.USD","LU0965509101.SGD","BK4566","LU2756315664.SGD","AMGN","IE000MB6IJN5.SGD","IE00BFSS7M15.SGD","LU0320765059.SGD","IE00BSNM7G36.USD","LU0985320562.USD","LU2347655156.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","SG9999001440.SGD","BK4588","BK4532","BK4568","LU0795875169.SGD","LU2087625088.SGD","LU1923622614.USD","LU0306807586.USD","LU0965509010.AUD","LU0211327993.USD","LU1496350502.SGD","CANC","LU0345769128.USD","LU1983299246.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","MEDX","IE00BDGV0183.EUR","LU1003077747.HKD","LU1496350171.SGD","IE00B4JS1V06.HKD","SG9999013999.USD","BK4534","GLAM","LU0385154629.USD","LU2211815571.USD","LU1066051811.HKD","LU0225771236.USD","LU0426417589.USD","LU0203201768.USD","LU2552382132.HKD","LU0965509283.SGD","TBXU","IXJ","LU0648001328.SGD","LU1093756168.USD","LU0321505868.SGD","LU1670627923.USD","LU0265550946.USD","LU1571399168.USD","IE00B7SZLL34.SGD","LU1934455863.HKD","ILDR","BK7067","LU0072461881.USD","LU0889565916.HKD","LU0466842654.USD","LU1267930573.SGD","BK4007","LU1814569148.SGD","PFE","IE00BK4W5M84.HKD","SGXZ81514606.USD","LU2456880835.USD","LU1934455194.USD","JDOC","IE0004445015.USD","LU1914381329.SGD","LU0124676726.USD","LU0823434740.USD","LU1059921491.USD","LU1121112475.USD","IE000BZT7R73.USD","IE00BJLML261.HKD","LU2236285917.USD","LU0162691827.USD","LU0210528500.USD","LU0316494557.USD","LU1712237335.SGD","LU0096364046.USD","LU2242652126.USD","LU1988902786.USD","LU0238689110.USD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU2125154935.USD","SG9999018865.SGD","LU1941712348.USD","PPH","LU2237443895.HKD","OZEM","IE00B4R5TH58.HKD","LU0689626769.HKD","LU1979441026.SGD","LU1894683348.USD","LU2271345857.HKD","SG9999014575.USD","LU0395794307.EUR","LU0070302665.USD","LU2357627491.SGD","SG9999002232.USD","LU0456855351.SGD","LU2471134952.CNY","LU2357305700.SGD","LU2087621335.USD","LU2265009873.SGD","FHLC","BK7501","GDOC","LU2264538146.SGD","IE0000B7K699.USD","LU2168564495.EUR","LU1894683264.USD","LU1069347547.HKD","PJP","CSL.AU","LU1670711040.USD","LU0553294199.USD","LU1868836914.USD","LU2433249047.HKD","LU0289739343.SGD","LU2168564222.USD","LU0320765489.SGD","LU0006306889.USD","LU1941712264.USD","IE00BZ1G4Q59.USD","LU1829250122.USD","LU0672654240.SGD","LU1917777945.USD","LU0965508806.USD","LU2491050154.USD","AZN","LU1145028129.USD","LU0472753341.HKD","LU1720051108.HKD","LU2461242641.AUD","LU0545039389.USD","LU0786609619.USD","LLY","LU0256863902.USD","SG9999014898.SGD","BK4139","LU0203347892.USD","04332","IE0005OL40V9.USD","IE00B7KXQ091.USD","LU0061475181.USD","LU0861579265.USD","LU0345770993.USD","LU2237443978.SGD","SG9999017495.SGD","BK4516","IBBQ","IE000M9KFDE8.USD","LU1057294990.SGD","LU2403377893.USD","VHT","LU2089284900.SGD","LU2471134879.HKD","LU2430703095.HKD","LU1323610961.USD","LU0320765646.SGD","SG9999015358.SGD","LU2361044865.SGD","GSK","LU2430703178.SGD","LU1066051225.USD","LU0640476718.USD","LU0079474960.USD","THNR","LU1720051017.SGD","LU1699723380.USD","IE00BN29S564.USD","LU1868837300.USD","ABBV","LU0130517989.USD","LU1804176565.USD","LU0321505439.SGD","SGXZ31699556.SGD","IE0002270589.USD","RXL","LU2168564149.EUR","LLYZ","LU2750360641.GBP","IE00BVYPNW00.USD","LU2896262040.SGD","LU0417517546.SGD","LU2125909247.SGD","BK7508","LU1267930490.SGD","IE00BFSS8Q28.SGD","LU1868836591.USD","IYH","LU0942090050.USD","LU1116320737.USD","LU1116320901.HKD","BMY","IE00BFXG1179.USD","LU0234572021.USD","LU1196500208.SGD","LU0174119429.USD","LU2129689605.HKD","LU0882574055.USD","LU1674673428.USD","LU2111349929.HKD","LU2360032135.SGD","MEDI","LU2746668974.SGD","MRK","GSKH","LU2552382215.SGD","LU0738911758.USD","LU2430703251.USD","LU1221951129.SGD","IE00B2B36J28.USD","BIIB","BK4599","AZNH","LU2471134523.USD","LU1732800096.USD","LU0868494708.USD","LU0211331839.USD","LU0345770308.USD","SG9999014880.SGD","FTXH","MHIP","LU2596442595.SGD","LU0210536198.USD","IE00BN8TJ469.HKD","LU1839511570.USD","LU1430594728.SGD","LU1261432733.SGD","LU1244550577.SGD","LU1674673691.USD","LU2491049909.HKD","LU0310799852.SGD","LU1066051498.USD","LU0353189763.USD","LU2592432038.USD","LU2108987350.USD","LU1366192091.USD","AGNG","LU0545562505.USD","SG9999014906.USD","LU2237443382.USD","LU0477156953.USD","LU0943347566.SGD","LU0122379950.USD","LU0820561909.HKD","LU2125909593.SGD","LU1670710588.SGD","IE00B19Z9P08.USD","IE00B1BXHZ80.USD","LU0823434583.USD","LU1064131342.USD","LU1629891620.HKD","GILD","SG9999015945.SGD","LU2112291526.USD","ELIL","LU0795875086.SGD","LU0511384066.AUD","LU1244550221.USD","LU2023250330.USD","LU0070217475.USD","LU0708995401.HKD","IE00BKVL7J92.USD","LU1023059063.AUD","LU0289961442.SGD","LU1551013342.USD","LU1244550494.USD","LU0106261372.USD","LU1201861249.SGD","LU0203345920.USD","IE00BJJMRX11.SGD","ELIS","LU0912757837.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU0471298777.SGD","LU2462591350.SGD","LU0320765992.SGD","LU0109394709.USD","SG9999014559.SGD","LU1032466523.USD","LU0708994859.HKD","LU0859254822.USD","SGXZ80539844.SGD","SG9999015978.USD","IE00BKDWB100.SGD","IE00B42XCP33.USD","LU0058720904.USD","LU0868494617.USD","SG9999015341.SGD","LU1974910355.USD","LU2129689431.USD","SG9999018857.SGD","BK7511","LU0211328371.USD","LU2552382058.USD","LU0345769631.USD","SGXZ51526630.SGD","LU0256863811.USD","LU0980610538.SGD","LU0323591593.USD","LU1585245621.USD","LU0661504455.SGD","LU1221951046.USD","LU0114720955.EUR","LU2417539215.USD","IE00B894F039.SGD","BK4585","LU2471134796.USD","LU2133065610.SGD","LU0432979614.USD","LU0265550359.USD","IE00B19Z3581.USD","SG9999015986.USD","LU0354030438.USD","LU2360106947.USD","LU0053666078.USD","LU1069344957.HKD","LU2089984988.USD","LU1989771016.USD","LU1868837136.USD","IE0001KFT4U8.USD","LU0689472784.USD","LU2168564065.EUR","LU0225283273.USD","IE0034235303.USD","LU2505996509.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658396419","title":"Shares of Vertex Pharma up 7.7% Premarket After Rival Genetic Disorder Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2658396419","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658396419?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:47","pubTimestamp":1786366034,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470WN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0256863811.USD","IDNA","LU0058720904.USD","IE00B4R5TH58.HKD","BK4532","IE0002141913.USD","IE00B19Z9Z06.USD","IE00BJT1NW94.SGD","SG9999001176.USD","VRTX","LU2362541273.HKD","LU2468319806.SGD","BK4139","IE00B19Z3581.USD","PBE","LU0889565916.HKD","LU2362541513.USD","TBXU","LU0417517546.SGD","LU2362540622.SGD","IE00BZ9MQY76.HKD","IE00BJJMRZ35.SGD","IBB","LU0320765992.SGD","LU1778281490.HKD","LU2417539215.USD","LU0079474960.USD","LU1093756325.SGD","IE00B2B36J28.USD","IBBQ","SG9999013999.USD","BK4585","LU1430594728.SGD","LU2236285917.USD","IE0009355771.USD","LU2237438978.USD","LU1585245621.USD","GNMX","BIB","BBH","IE0002270589.USD","LU2324357040.USD","BK4567","LU2456880835.USD","SGXZ57979304.SGD","LU1035775433.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658935018","title":"Erasca Appoints Charles Fuchs as President of R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=2658935018","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658935018?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:07","pubTimestamp":1786363655,"startTime":"0","endTime":"0","summary":"Erasca appoints Charles Fuchs as president of R&DErasca named Charles S. Fuchs president of research and development, effective immediately.Fuchs most recently served as chief medical officer at Tubul","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL46mF8m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1066051498.USD","LU1571399168.USD","TMED","IBB","LU0965509010.AUD","LU1839511570.USD","LU2087621335.USD","LU1430594728.SGD","BK4583","LU2210150020.SGD","LU1023059063.AUD","BK4568","LU0320765992.SGD","LU0114720955.EUR","LU0861579265.USD","LU1061106388.HKD","LU1934455863.HKD","LU0965509283.SGD","BMED","NDAQ","LU0289739699.SGD","LU1585245621.USD","BK4578","LU0058720904.USD","IBBQ","LU1057294990.SGD","LU2468319806.SGD","BK4532","BK4585","GILD","MEDI","TBXU","LU1934455194.USD","LU0965509101.SGD","ERAS","IE0002270589.USD","LU1778281490.HKD","LU0122379950.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU1037948897.HKD","LU1037948541.HKD","BBH","BIB","BCDF","SG9999014021.USD","IE00B19Z3B42.SGD","SG9999015952.SGD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658270935","title":"Sionna Scraps Genetic Disorder Drug Program After Trial Setback; Shares Tank","url":"https://stock-news.laohu8.com/highlight/detail?id=2658270935","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658270935?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:03","pubTimestamp":1786363413,"startTime":"0","endTime":"0","summary":"Sionna scraps genetic disorder drug program after trial setback; shares tankAug 10 (Reuters)-Sionna TherapeuticsSION.Osaid on Monday it would stop developing its experimental drug as an addition to st","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470O4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","SG9999001176.SGD","IE00B4R5TH58.HKD","IE00B894F039.SGD","LU2417539215.USD","LU2362540622.SGD","BK4585","SION","IE0009355771.USD","BK4139","IE00BFTCPJ56.SGD","LU1585245621.USD","BBH","LU0058720904.USD","GNMX","IDNA","IE00B19Z3581.USD","LU0256863811.USD","BK4588","LU0320765992.SGD","LU0061475181.USD","LU2456880835.USD","IE00B19Z3B42.SGD","LU0823416689.USD","PBE","BK4532","LU2236285917.USD","IE0002270589.USD","LU1674673691.USD","TBXU","LU2324357040.USD","LU2362541513.USD","LU0289739699.SGD","IE00B19Z9Z06.USD","LU0417517546.SGD","SG9999013999.USD","BK4533","IE00B2B36J28.USD","LU1035775433.USD","BK4567","IBB","IBBQ","IE00B19Z9P08.USD","LU2362541273.HKD","VRTX","LU1069344957.HKD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU1674673428.USD","SGXZ57979304.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658354779","title":"Analysts’ Top Healthcare Picks: Xencor (XNCR), Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658354779","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658354779?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:50","pubTimestamp":1786362616,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Xencor (XNCR), Revolution Medicines (RVMD) and Roiva...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-xencor-xncr-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-xencor-xncr-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","IE00B4R5TH58.HKD","IE0002141913.USD","BK4588","IE0009354923.USD","IE00BJT1NW94.SGD","LU0109394709.USD","BK4139","LU0029874061.USD","XLV","LU0889565916.HKD","XNCR","BK4137","PTH","IE00BJJMRZ35.SGD","LU0320765992.SGD","CANC","BK4581","IE00B2B36J28.USD","LU0128526141.USD","BK4585","RVMD","IE0009355771.USD","XBI","BBH","LABU","HCSG","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658110987","title":"BeOne Medicines partners with Revolution Medicines for clinical development","url":"https://stock-news.laohu8.com/highlight/detail?id=2658110987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658110987?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:15","pubTimestamp":1786356922,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC) and Revolution Medicines (RVMD) announced a multi-part collaboration including: a clinical collaboration to evaluate drug com...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-medicines-partners-with-revolution-medicines-for-clinical-development-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-medicines-partners-with-revolution-medicines-for-clinical-development-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","BBH","CANC","IE0009354923.USD","LU0320765992.SGD","PTH","IDNA","IE0002141913.USD","IE00BJJMRZ35.SGD","RVMD","BK4585","BK4526","BK4139","ONC","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4588","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982220","title":"BeOne Medicines Teams with Revolution Medicines on RAS Cancer Drug Development, Asia Rights Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982220","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982220?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:01","pubTimestamp":1786356092,"startTime":"0","endTime":"0","summary":"BeOne Medicines teams with Revolution Medicines on RAS cancer drug development, Asia rights dealBeOne Medicines AG entered a multi-part collaboration with Revolution Medicines covering clinical develo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL9VYymL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","RVMD","BBH","BK0239","IE0009355771.USD","688235","IE0009354923.USD","PTH","LU0109394709.USD","BK4139","CANC","IDNA","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982475","title":"Beone Medicines - Receives Exclusive Rights to Four Revolution Medicines Assets in Select Asian Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982475","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982475?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:00","pubTimestamp":1786356000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4MKT8N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","PTH","IE0002141913.USD","IE00B4R5TH58.HKD","688235","IE0009355771.USD","LU0889565916.HKD","IDNA","IE00BJJMRZ35.SGD","BK0239","BBH","BK4139","IE00BJT1NW94.SGD","RVMD","CANC","IE0009354923.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982449","title":"Beone Medicines - to Fund and Conduct Global Phase 3 Study for Ras(on) Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982449","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982449?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:00","pubTimestamp":1786356000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4MKT8N:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0320765992.SGD","LU0889565916.HKD","IE0002141913.USD","IE00B4R5TH58.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","PTH","BBH","CANC","688235","IE0009354923.USD","RVMD","BK4139","IDNA","BK0239","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658296982","title":"Beone Medicines - Revolution Medicines Eligible for Milestone Payments and Tiered Royalties in Partnered Region","url":"https://stock-news.laohu8.com/highlight/detail?id=2658296982","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658296982?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:00","pubTimestamp":1786356000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nTUA4MKT8N:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","688235","PTH","BBH","IDNA","IE0009354923.USD","IE0002141913.USD","LU0320765992.SGD","CANC","BK0239","LU0889565916.HKD","LU0109394709.USD","IE00B2B36J28.USD","RVMD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658891989","title":"Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2658891989","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658891989?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:33","pubTimestamp":1786350780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 0.9% to 5.05 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.0% to 25937.49.The stock's fall snapped a two-day winning streak.Sino Biopharmaceutical Ltd. closed 45% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.7% and Amgen Inc. remained unchanged.Trading volume totaled 86.6 million shares, compared to the 50-day average of 101.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","LU1023059063.AUD","BIB","BK1515","BK4581","IE00BJJMRZ35.SGD","LU0109394709.USD","SG9999001440.SGD","PBE","BK4585","IBBQ","BK4588","BK1589","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0002141913.USD","LU2112291526.USD","IE00BZ08YT58.USD","LU1983299246.USD","LU1057294990.SGD","LU2242646821.SGD","LU0889565916.HKD","BK4566","LU0289739699.SGD","IE00BZ08YS42.EUR","LU2089984988.USD","BK1521","IE0009355771.USD","LU0058720904.USD","LU0868494617.USD","BK4139","BK4534","LU1571399168.USD","LU2468319806.SGD","BBH","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","HK0000165453.HKD","IBB","IE00BZ08YR35.GBP","LU0122379950.USD","TBXU","01177","LU2242652126.USD","BK1191","LU1061106388.HKD","AMGN","PJP","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658042600","title":"Amgen Inc : HSBC Raises Target Price to $445 from $425","url":"https://stock-news.laohu8.com/highlight/detail?id=2658042600","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658042600?lang=en_us&edition=fundamental","pubTime":"2026-08-10 14:30","pubTimestamp":1786343453,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN44709K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0122379950.USD","BK4585","BBH","IE00B4R5TH58.HKD","LU1023059063.AUD","PBE","LU0868494617.USD","IE00BJJMRZ35.SGD","BK4581","IBBQ","LU0109394709.USD","LU1057294990.SGD","LU2468319806.SGD","LU0889565916.HKD","PJP","BK4588","BK4566","IE0002141913.USD","BK4534","LU1983299246.USD","IE00BFTCPJ56.SGD","LU2242652126.USD","LU0058720904.USD","SG9999001440.SGD","TBXU","IE0009355771.USD","LU2089984988.USD","LU2112291526.USD","LU0289739699.SGD","LU1571399168.USD","IBB","LU0320765992.SGD","AMGN","BK4533","BIB","BK4599","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4139","IE00B2B36J28.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658006076","title":"Revolution Medicines, Inc. : JP Morgan Raises Target Price to $227 from $205","url":"https://stock-news.laohu8.com/highlight/detail?id=2658006076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658006076?lang=en_us&edition=fundamental","pubTime":"2026-08-10 14:04","pubTimestamp":1786341899,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nFWN447095:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","IDNA","BK4139","IE0009355771.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","RVMD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE0009354923.USD","CANC","LU0109394709.USD","PTH","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BBH","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567890","title":"Analysts Are Bullish on These Healthcare Stocks: Spyre Therapeutics (SYRE), Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567890","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567890?lang=en_us&edition=fundamental","pubTime":"2026-08-08 22:40","pubTimestamp":1786200025,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Spyre Therapeutics (SYRE) and Revolution Medicines (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-spyre-therapeutics-syre-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-spyre-therapeutics-syre-revolution-medicines-rvmd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","BBH","RVMD","IE00BJT1NW94.SGD","SYRE","CANC","PTH","LU0889565916.HKD","IE0009354923.USD","IDNA","LFSC","BK4139","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657402621","title":"Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657402621","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657402621?lang=en_us&edition=fundamental","pubTime":"2026-08-08 06:46","pubTimestamp":1786142807,"startTime":"0","endTime":"0","summary":"Amgen SVP, Chief Compliance Officer Nancy Grygiel sells 2,970 shares for $1.2 millionAmgen SVP and chief compliance officer Nancy A. Grygiel exercised stock options on Aug. 6, 2026, acquiring 2,970 co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL4RnJzY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Amgen SVP, Chief Compliance Officer Nancy Grygiel Sells 2,970 Shares for $1.2 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1571399168.USD","LU2112291526.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4599","LU2242652126.USD","IE0009355771.USD","BIB","IBBQ","BBH","LU2468319806.SGD","LU0122379950.USD","PBE","BK4566","LU0320765992.SGD","LU2089984988.USD","LU0868494617.USD","BK4581","LU0058720904.USD","LU1061106388.HKD","BK4534","LU0109394709.USD","AMGN","IE00B4R5TH58.HKD","LU1023059063.AUD","LU1983299246.USD","LU2242646821.SGD","SG9999001440.SGD","LU0289739699.SGD","LU0889565916.HKD","TBXU","IE00BFTCPJ56.SGD","BK4585","BK4588","IBB","PJP","BK4139","IE0002141913.USD","BK4533","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657621940","title":"Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2657621940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657621940?lang=en_us&edition=fundamental","pubTime":"2026-08-08 06:05","pubTimestamp":1786140332,"startTime":"0","endTime":"0","summary":"Michael Okunewitch, an analyst from Maxim Group, reiterated the Buy rating on Gilead Sciences. The associated price target remains the same with $1...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/gilead-strong-hiv-and-oncology-growth-underpins-reiterated-buy-rating-and-unchanged-165-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/gilead-strong-hiv-and-oncology-growth-underpins-reiterated-buy-rating-and-unchanged-165-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","BK4550","BK4588","LU0965509010.AUD","LU1839511570.USD","BK4139","IE00BKVL7J92.USD","LU2087621335.USD","LU1430594728.SGD","IE00BZ1G4Q59.USD","BMED","LU1066053197.SGD","LU1934455194.USD","LU1037948897.HKD","LU0823416689.USD","LU0965509283.SGD","LU1061106388.HKD","LU2089984988.USD","SG9999015952.SGD","LU1674673428.USD","IE00B19Z3581.USD","LU0058720904.USD","LU0861579265.USD","MEDI","LU0965508806.USD","LU0889565916.HKD","BK4583","IE0002270589.USD","LU1066051498.USD","GILD","TMED","LU1057294990.SGD","LU1934455863.HKD","BK4532","LU0320765992.SGD","LU0114720955.EUR","SG9999015986.USD","BK4568","LU0882574055.USD","LU1674673691.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0289739699.SGD","BIB","IBBQ","LU1934455277.USD","TBXU","IE00B7SZLL34.SGD","BBH","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657749626","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2657749626","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657749626?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:36","pubTimestamp":1786134960,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.80% to $133.21 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.62% to 7,757.64 and the Dow Jones Industrial Average  rising 0.28% to 54,036.93.The stock's rise snapped a two-day losing streak.Gilead Sciences Inc. closed 15.31% below its 52-week high of $157.29, which the company achieved on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson  rose 0.88% to $259.24, Pfizer Inc.  rose 2.14% to $26.76, and Abbott Laboratories  fell 0.14% to $107.81.Trading volume  eclipsed its 50-day average volume of 8.2 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 7, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","GILD","LU1934455194.USD","LU1066051498.USD","BK4139","LU0861579265.USD","LU2087621335.USD","LU2112291526.USD","LU0965509010.AUD","LU2324357040.USD","TBXU","BK4585","IE00B7SZLL34.SGD","LU1839511570.USD","LU1674673691.USD","LU0889565916.HKD","BBH","IBBQ","SG9999015952.SGD","IE00B3T34201.USD","LU1057294990.SGD","LU1430594728.SGD","BK4583","IE00B19Z3B42.SGD","BIB","SG9999015986.USD","MEDI","IE00B19Z3581.USD","BK4568","LU1037948541.HKD","IE00BKVL7J92.USD","LU1037948897.HKD","LU0114720955.EUR","LU0823416689.USD","LU0965509101.SGD","BMED","LU0965509283.SGD","LU1934455863.HKD","BK4566","IE0002270589.USD","LU0965508806.USD","IE00BSNM7G36.USD","LU1585245621.USD","IE00BZ1G4Q59.USD","SG9999015978.USD","BK4578","LU1571399168.USD","LU1778281490.HKD","LU1934455277.USD","BK4550","LU0122379950.USD","BK4532","BK4588","LU1066053197.SGD","LU0882574055.USD","LU2468319806.SGD","LU0234570918.USD","LU1674673428.USD","LU2089984988.USD","IBB","LU0109394709.USD","LU0289739699.SGD","LU1023059063.AUD","LU0058720904.USD","LU1061106388.HKD","TMED","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626282","title":"Moderna Inc. Stock Climbs 9.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626282","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626282?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:33","pubTimestamp":1786134780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 9.9% to $59.17 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.3% to 26,690.62 and the Dow Jones Industrial Average rising 0.3% to 54,036.93.The stock's rise snapped a two-day losing streak.Moderna Inc. closed 30.9% short of its 52-week high of $85.60, which the company reached on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.9% to $259.24, Pfizer Inc. rose 2.1% to $26.76, and Gilead Sciences Inc. rose 1.80% to $133.21.Trading volume totaled 6.8 million, compared to the 50-day average of 7.2 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","BIB","MRNA","SG9999015952.SGD","LU0965509101.SGD","LU1585245621.USD","BBH","MEDI","LU1934455863.HKD","BK4550","WDNA","BK4583","GILD","LU0861579265.USD","LU2468319806.SGD","IDNA","MRNY","LU1066051498.USD","LU0965509010.AUD","BK4588","LU0320765992.SGD","LU1037948897.HKD","LU1066053197.SGD","IE00B19Z3B42.SGD","LGHT","LU1934455277.USD","LU1023059063.AUD","GNOM","LU2112291526.USD","LU0823416689.USD","LU0882574055.USD","BK4532","TMED","BK4551","IE0002270589.USD","LU0889565916.HKD","LU1037948541.HKD","LU1430594728.SGD","SG9999015978.USD","TBXU","IE00B7SZLL34.SGD","LU0114720955.EUR","IBB","IBBQ","LU1674673428.USD","IE00BZ1G4Q59.USD","BK4566","BMED","BK4501","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657469640","title":"Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock is Tumbling.","url":"https://stock-news.laohu8.com/highlight/detail?id=2657469640","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657469640?lang=en_us&edition=fundamental","pubTime":"2026-08-08 00:36","pubTimestamp":1786120560,"startTime":"0","endTime":"0","summary":"Replimune Group received Food and Drug Administration clearance for its experimental skin cancer drug, concluding a saga that saw regulators twice deny its application. The stock was falling anyway.Th","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4534","AMGN","PBE","IE0002141913.USD","FTXH","PJP","TBXU","LU0225284248.USD","BK4585","LU0306807586.USD","IHE","LU1093756325.SGD","BBH","IBBQ","LU0061475181.USD","LU1868837136.USD","LU1989771016.USD","LU0985481810.HKD","IOVA","LU1670711123.USD","LU2133065610.SGD","BIB","REPL","LU1718418525.SGD","BK4007","LU1883839398.USD","LU0114720955.EUR","LU2242646821.SGD","IE00BSNM7G36.USD","LU1585245621.USD","LU0237698245.USD","LU1983299246.USD","BK4533","LU0868494617.USD","BK4532","LU2468319806.SGD","LU2089984988.USD","LU1323610961.USD","IBB","LU1093756168.USD","LU0289739699.SGD","LU0306806265.USD","LU1023059063.AUD","LU1868836591.USD","LU0225771236.USD","LU1061106388.HKD","SG9999001440.SGD","LU0321505868.SGD","BMY"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}